Detalhe da pesquisa
1.
Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis.
N Engl J Med
; 377(16): 1537-1550, 2017 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045212
2.
Patient-Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two-Year Results From an International Phase III Study.
Arthritis Care Res (Hoboken)
; 75(8): 1804-1814, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36710243
3.
Long-Term Maintenance of Clinical Responses by Individual Patients With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Abatacept.
Arthritis Care Res (Hoboken)
; 75(11): 2259-2266, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37221146
4.
[Relapsing risk and obstetric-neonatal outcome in pregnancy and systemic lupus erythematosus]. / Reactivación y pronóstico obstétrico-neonatal en lupus y embarazo.
Rev Med Inst Mex Seguro Soc
; 50(4): 355-61, 2012.
Artigo
em Espanhol
| MEDLINE | ID: mdl-23234736
5.
[Pregnancy outcomes before and after the onset of rheumatoid arthritis]. / Desenlace obstétrico antes y después del inicio de la artritis reumatoide.
Rev Med Inst Mex Seguro Soc
; 49(6): 599-604, 2011.
Artigo
em Espanhol
| MEDLINE | ID: mdl-22176821
6.
Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Results From a Phase III Open-Label Study.
Arthritis Rheumatol
; 70(7): 1144-1154, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29481737